Impact of tumour burden on chemotherapy-induced nausea and vomiting.

We investigated how residual tumour burden after cytoreductive surgery was related to the occurrence of acute and delayed nausea and vomiting in 101 ovarian cancer patients receiving their first chemotherapy course. The anti-emetic treatment included ondansetron combined with dexamethasone or placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: Hursti, T. J., Avall-Lundqvist, E., Börjeson, S., Fredrikson, M., Fürst, C. J., Steineck, G., Peterson, C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077107/
https://www.ncbi.nlm.nih.gov/pubmed/8855984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077107/
https://www.ncbi.nlm.nih.gov/pubmed/8855984

Ejemplares similares